FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Primitive. Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Case insensitive SNOMED CT core
    3442102012 2 (qualifier value) en Fully specified name Active Case insensitive SNOMED CT core
    3442103019 2 en Synonym Active Case insensitive SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Some
    2 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Drospirenone 500 microgram and estradiol 1 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Fluoxetine hydrochloride 50 mg and olanzapine 12 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Hydralazine hydrochloride 25 mg and hydrochlorothiazide 25 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Eprosartan mesilate 600 mg and hydrochlorothiazide 12.5 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Hydralazine hydrochloride 50 mg and hydrochlorothiazide 50 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Furosemide 40 mg and triamterene 50 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Naproxen sodium 500 mg and sumatriptan succinate 85 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Furosemide 20 mg and spironolactone 50 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Lopinavir 133.3 mg and ritonavir 33.3 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Ferrous fumarate 305 mg and folic acid 350 microgram oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Fluoxetine hydrochloride 50 mg and olanzapine 6 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Ferrous fumarate 322 mg and folic acid 350 microgram oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Glimepiride 1 mg and rosiglitazone maleate 4 mg oral tablet Count of base of active ingredient False 2 Inferred relationship Some
    Pethidine hydrochloride 50 mg and promethazine hydrochloride 25 mg oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Cyclophosphamide (as cyclophosphamide monohydrate) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Cefoxitin (as cefoxitin sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Aztreonam 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Aspirin DL-lysine 900 mg and metoclopramide hydrochloride 10 mg oral powder sachet Count of base of active ingredient False 2 Inferred relationship Some
    Benorilate 2 g granules for oral suspension sachet Has presentation strength numerator value False 2 Inferred relationship Some 1
    Amoxicillin (as amoxicillin sodium) 500 mg and clavulanic acid (as clavulanate potassium) 100 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Deferoxamine mesylate 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Ampicillin (as ampicillin sodium) 250 mg and flucloxacillin (as flucloxacillin sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Ceftazidime (as ceftazidime pentahydrate) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Ceftriaxone (as ceftriaxone sodium) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Cefpirome (as cefpirome sulfate) 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Ifosfamide 2 g powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Dalfopristin (as dalfopristin mesilate) 350 mg and quinupristin (as quinupristin mesilate) 150 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Codeine phosphate 30 mg and paracetamol 500 mg effervescent powder for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Codeine phosphate 60 mg and paracetamol 1 g effervescent powder for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Raltitrexed 2 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Ispaghula husk 3.5 g and mebeverine hydrochloride 135 mg granules for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Somatropin(rbe) 2 mg powder for solution for injection syringe Has presentation strength numerator value False 2 Inferred relationship Some 1
    Clavulanic acid (as clavulanate potassium) 200 mg and ticarcillin (as ticarcillin disodium) 3 g powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet Count of base of active ingredient False 2 Inferred relationship Some
    Galactose 2.49 g and palmitic acid 2.5 mg powder for suspension for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Galactose 3.99 g and palmitic acid 4 mg powder for suspension for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Mitomycin 2 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 1
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Has presentation strength numerator value False 2 Inferred relationship Some 2
    Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial Count of base of active ingredient False 2 Inferred relationship Some
    Dantron 10 mg/mL and docusate sodium 12 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Dihydrocodeine tartrate 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Ferric ammonium citrate 16 mg/mL and folic acid 500 microgram/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Ferric ammonium citrate 16 mg/mL and folic acid 100 microgram/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Hydroxyzine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Orciprenaline sulfate 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Diazepam 2 mg/mL oral suspension Has concentration strength numerator value False 2 Inferred relationship Some 1
    Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Amoxicillin (as amoxicillin trihydrate) 50 mg/mL and clavulanic acid (as clavulanate potassium) 12.5 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Diphenhydramine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Morphine sulfate 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Prednisolone 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Paroxetine (as paroxetine hydrochloride) 2 mg/mL oral suspension Has concentration strength numerator value False 2 Inferred relationship Some 1
    Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Spironolactone 2 mg/mL oral suspension Has concentration strength numerator value False 2 Inferred relationship Some 1
    Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Ampicillin (as ampicillin trihydrate) 25 mg/mL and flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Methadone hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Pholcodine 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Periciazine 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Amoxicillin (as amoxicillin trihydrate) 25 mg/mL and clavulanic acid (as clavulanate potassium) 6.25 mg/mL oral suspension Count of base of active ingredient False 2 Inferred relationship Some
    Dicycloverine hydrochloride 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Lopinavir 80 mg/mL and ritonavir 20 mg/mL oral solution Count of base of active ingredient False 2 Inferred relationship Some
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Phenothrin 2 mg/mL cutaneous lotion Has concentration strength numerator value False 2 Inferred relationship Some 1
    Midazolam (as midazolam hydrochloride) 2 mg/mL oral solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Sodium fluoride 2 mg/g oromucosal solution Has concentration strength numerator value False 2 Inferred relationship Some 1
    Ibuprofen 50 mg/g and levomenthol 30 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Retinol 4000 international unit and vitamin D 400 international unit oral capsule Count of base of active ingredient False 2 Inferred relationship Some
    Benzocaine 20 mg/g and salicylamide 50 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone acetate 15 mg/g and neomycin sulfate 5 mg/g ear or eye ointment Count of base of active ingredient False 2 Inferred relationship Some
    Dithranol 2.5 mg/g and salicylic acid 16 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone dipropionate 640 microgram/g and clotrimazole 10 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops solution Count of base of active ingredient False 2 Inferred relationship Some
    Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear or eye or nose drops Count of base of active ingredient False 2 Inferred relationship Some
    Carbomer-980 2 mg/g eye gel Has concentration strength numerator value False 2 Inferred relationship Some 1
    Hydrocortisone acetate 10 mg/g and sodium fusidate 20 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray Count of base of active ingredient False 2 Inferred relationship Some
    Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Benzoyl peroxide 50 mg/g and clindamycin (as clindamycin phosphate) 10 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Lactic acid 40 mg/g and salicylic acid 120 mg/g cutaneous gel Count of base of active ingredient False 2 Inferred relationship Some
    Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Some
    Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous cream Count of base of active ingredient False 2 Inferred relationship Some

    Start Previous Page 21 of 24 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start